{"id":52776,"date":"2026-02-23T06:39:00","date_gmt":"2026-02-23T06:39:00","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/primary-biliary-cholangitis-therapeutics-market-mordor\/"},"modified":"2026-09-25T19:46:25","modified_gmt":"2026-09-25T10:46:25","slug":"primary-biliary-cholangitis-therapeutics-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/primary-biliary-cholangitis-therapeutics-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \uc6d0\ubc1c\uc131 \ub2f4\uc999\uc131 \ub2f4\uad00\uc5fc \uce58\ub8cc\uc81c \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026-2031\ub144)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/primary-biliary-cholangitis-therapeutics-market_Primary_Biliary_Cholangitis_PBC_Therapeutics_COmpanies.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/primary-biliary-cholangitis-therapeutics-market-size-image-1770825224346.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 FXR \uc791\uc6a9\uc81c\uc758 \ub300\uc0c1\uc131 \uac04\uacbd\ubcc0\uc99d\uc73c\ub85c\uc758 \uc801\uc751\uc99d \ud655\ub300<\/li>\n<li class=\"toc-level-3\">4.2.2 PPAR \uc791\uc6a9\uc81c\uc5d0 \ub300\ud55c \uc2e0\uc18d \uc2b9\uc778<\/li>\n<li class=\"toc-level-3\">4.2.3 \ube44\uc6a9 \ubbfc\uac10 \uc2dc\uc7a5\uc5d0 \uce68\ud22c\ud558\ub294 \ucd5c\uc801\ud654\ub41c UDCA \uc81c\ub124\ub9ad<\/li>\n<li class=\"toc-level-3\">4.2.4 \uc0dd\ud654\ud559\uc801 \ubc18\uc751\uc790\ub97c \uc9c0\uc9c0\ud558\ub294 \uc2e4\uc81c \uc784\uc0c1 \ub370\uc774\ud130<\/li>\n<li class=\"toc-level-3\">4.2.5 AI \uae30\ubc18 \uc870\uae30 \uc9c4\ub2e8\uc774 \uce58\ub8cc\uc81c \uc218\uc694\ub97c \uacac\uc778<\/li>\n<li class=\"toc-level-3\">4.2.6 \ubcd1\uc6a9 \uc694\ubc95 \uc784\uc0c1 \uc2dc\ud5d8 \ud65c\ub3d9 \uc99d\uac00<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \uace0\uc6a9\ub7c9 FXR \uc791\uc6a9\uc81c \uc0ac\uc6a9 \uc2dc \uac00\ub824\uc6c0\uc99d \uc704\ud5d8<\/li>\n<li class=\"toc-level-3\">4.3.2 \uadfc\ubcd1\uc99d \uad00\ub828 \ud53c\ube0c\ub808\uc774\ud2b8 \uc911\ub2e8<\/li>\n<li class=\"toc-level-3\">4.3.3 \uc774\uc2dd \uc5c6\ub294 \uc0dd\uc874\uc728 \ud3c9\uac00 \uc9c0\ud45c \ubd80\uc871<\/li>\n<li class=\"toc-level-3\">4.3.4 \uc77c\ubc18\uc758\ub4e4 \uc0ac\uc774\uc758 \uc81c\ud55c\ub41c \uc778\uc2dd<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \uaddc\uc81c \ud658\uacbd<\/li>\n<li class=\"toc-level-2\">4.5 \uae30\uc220 \uc804\ub9dd<\/li>\n<li class=\"toc-level-2\">4.6 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.6.1 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.6.2 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.6.3 \uacf5\uae09\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.6.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.6.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21 (USD \uac00\uce58)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uc57d\ubb3c \uc885\ub958\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 \uc6b0\ub974\uc18c\ub370\uc625\uc2dc\ucf5c\uc0b0<\/li>\n<li class=\"toc-level-3\">5.1.2 \uc624\ubca0\ud2f0\ucf5c\uc0b0<\/li>\n<li class=\"toc-level-3\">5.1.3 PPAR \uc791\uc6a9\uc81c<\/li>\n<li class=\"toc-level-3\">5.1.4 \ud53c\ube0c\ub808\uc774\ud2b8<\/li>\n<li class=\"toc-level-3\">5.1.5 \uae30\ud0c0 \uc57d\ubb3c \uc885\ub958<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \uc791\uc6a9 \uae30\uc804\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 FXR \uc791\uc6a9\uc81c<\/li>\n<li class=\"toc-level-3\">5.2.2 PPAR \u03b1\/\u03b4 \uc791\uc6a9\uc81c<\/li>\n<li class=\"toc-level-3\">5.2.3 \ub2f4\uc999\uc0b0 \uc870\uc808\uc81c<\/li>\n<li class=\"toc-level-3\">5.2.4 \ud56d\uc12c\uc720\ud654\uc81c<\/li>\n<li class=\"toc-level-3\">5.2.5 \uba74\uc5ed \uc870\uc808\uc81c<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \uce58\ub8cc \ub2e8\uacc4\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 1\ucc28 \uce58\ub8cc<\/li>\n<li class=\"toc-level-3\">5.3.2 2\ucc28 \uce58\ub8cc<\/li>\n<li class=\"toc-level-3\">5.3.3 \ubcd1\uc6a9 \uce58\ub8cc<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \uc720\ud1b5 \ucc44\ub110\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \ubcd1\uc6d0 \uc57d\uad6d<\/li>\n<li class=\"toc-level-3\">5.4.2 \uc18c\ub9e4 \uc57d\uad6d<\/li>\n<li class=\"toc-level-3\">5.4.3 \uc628\ub77c\uc778 \uc57d\uad6d<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.5 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.5.1 \ubd81\ubbf8\n<ul>\n<li class=\"toc-level-4\">5.5.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.5.1.3 \uba55\uc2dc\ucf54<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-3\">5.5.2 \uc720\ub7fd\n<ul>\n<li class=\"toc-level-4\">5.5.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.5.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.5.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.5.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.5.2.6 \uc720\ub7fd \uae30\ud0c0 \uc9c0\uc5ed<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-3\">5.5.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591\n<ul>\n<li class=\"toc-level-4\">5.5.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.5.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.5.3.4 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.5.3.5 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.3.6 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uae30\ud0c0 \uc9c0\uc5ed<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-3\">5.5.4 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74\n<ul>\n<li class=\"toc-level-4\">5.5.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.5.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.5.4.3 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74 \uae30\ud0c0 \uc9c0\uc5ed<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-3\">5.5.5 \ub0a8\ubbf8\n<ul>\n<li class=\"toc-level-4\">5.5.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.5.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.5.5.3 \ub0a8\ubbf8 \uae30\ud0c0 \uc9c0\uc5ed<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.3 \uae30\uc5c5 \ud504\ub85c\ud544 (\uae00\ub85c\ubc8c \uac1c\uc694, \uc2dc\uc7a5 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34 \uc815\ubcf4(\uc0ac\uc6a9 \uac00\ub2a5\ud55c \uacbd\uc6b0), \uc804\ub7b5 \uc815\ubcf4, \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 &amp; \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ud3ec\ud568)\n<ul>\n<li class=\"toc-level-3\">6.3.1 Intercept Pharmaceuticals<\/li>\n<li class=\"toc-level-3\">6.3.2 Teva Pharmaceutical Industries<\/li>\n<li class=\"toc-level-3\">6.3.3 Viatris (Mylan)<\/li>\n<li class=\"toc-level-3\">6.3.4 Ipsen (pharma)<\/li>\n<li class=\"toc-level-3\">6.3.5 Genfit SA<\/li>\n<li class=\"toc-level-3\">6.3.6 CymaBay Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.7 Dr Falk Pharma<\/li>\n<li class=\"toc-level-3\">6.3.8 Albireo (now Ipsen)<\/li>\n<li class=\"toc-level-3\">6.3.9 Mirum Pharmaceuticals<\/li>\n<li class=\"toc-level-3\">6.3.10 Gilead Sciences<\/li>\n<li class=\"toc-level-3\">6.3.11 Novartis AG<\/li>\n<li class=\"toc-level-3\">6.3.12 Zydus LifeSciences<\/li>\n<li class=\"toc-level-3\">6.3.13 Dr Reddy\u2019s Laboratories<\/li>\n<li class=\"toc-level-3\">6.3.14 Pfizer Inc.<\/li>\n<li class=\"toc-level-3\">6.3.15 Johnson &amp; Johnson (Janssen)<\/li>\n<li class=\"toc-level-3\">6.3.16 Allergan Inc.<\/li>\n<li class=\"toc-level-3\">6.3.17 Endo International<\/li>\n<li class=\"toc-level-3\">6.3.18 Glenmark Pharmaceuticals<\/li>\n<li class=\"toc-level-3\">6.3.19 Sumitomo Dainippon Pharma<\/li>\n<li class=\"toc-level-3\">6.3.20 Eli Lilly &amp; Company<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c &amp; \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\uc6d0\ubc1c\uc131 \ub2f4\uc999\uc131 \ub2f4\uad00\uc5fc(PBC) \uce58\ub8cc\uc81c \uc2dc\uc7a5 \uac1c\uc694 (2026-2031)<\/p>\n<p>\uc6d0\ubc1c\uc131 \ub2f4\uc999\uc131 \ub2f4\uad00\uc5fc(Primary Biliary Cholangitis, PBC) \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc740 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 7.86%\uc758 \uacac\uace0\ud55c \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud558\uba70, 2025\ub144 0.86\uc5b5 \ub2ec\ub7ec\uc5d0\uc11c 2026\ub144 0.93\uc5b5 \ub2ec\ub7ec, \uadf8\ub9ac\uace0 2031\ub144\uc5d0\ub294 1.35\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\uc5d0 \uc774\ub97c \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \ubd81\ubbf8 \uc9c0\uc5ed\uc774 \uac00\uc7a5 \ud070 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \uc720\uc9c0\ud558\ub294 \ubc18\uba74, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \uac00\uc7a5 \ube60\ub978 \uc131\uc7a5\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc2dc\uc7a5 \uc9d1\uc911\ub3c4\ub294 \uc911\uac04 \uc218\uc900\uc774\uba70, \uc8fc\uc694 \uae30\uc5c5\uc73c\ub85c\ub294 Allergan Inc., Glenmark Pharmaceuticals, Intercept Pharmaceuticals, Teva Pharmaceutical Industries, Viatris (Mylan) \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4. \ubcf8 \ubcf4\uace0\uc11c\uc758 \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc608\uce21 \uc218\uce58\ub294 2026\ub144 1\uc6d4 \uae30\uc900 \ucd5c\uc2e0 \ub370\uc774\ud130\uc640 \ud1b5\ucc30\ub825\uc744 \ubc18\uc601\ud558\uc5ec Mordor Intelligence\uc758 \ub3c5\uc810\uc801\uc778 \ucd94\uc815 \ud504\ub808\uc784\uc6cc\ud06c\ub97c \uc0ac\uc6a9\ud558\uc5ec \uc0dd\uc131\ub418\uc5c8\uc2b5\ub2c8\ub2e4.<\/p>\n<p># \uc8fc\uc694 \uc131\uc7a5 \ub3d9\ub825<\/p>\n<p>PBC \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc758 \uc131\uc7a5\uc740 \uc5ec\ub7ec \uc694\uc778\uc5d0 \uc758\ud574 \uac15\ub825\ud558\uac8c \ub4b7\ubc1b\uce68\ub429\ub2c8\ub2e4.<br \/>\n*   PPAR \uc791\uc6a9\uc81c\uc758 \uc2e0\uc18d \uc2b9\uc778: \uc5d8\ub77c\ud53c\ube0c\ub77c\ub178(elafibranor)\uc640 \uc140\ub77c\ub378\ud30c(seladelpar)\uc640 \uac19\uc740 PPAR \uc791\uc6a9\uc81c\ub4e4\uc774 \uc54c\uce7c\ub9ac\uc131\uc778\uc0b0\ubd84\ud574\ud6a8\uc18c(ALP) \uc218\uce58\ub97c \ub0ae\ucd94\ub294 \ub370 \ud6a8\uacfc\uc801\uc774\uba70, \uc774\ub294 PBC \uce58\ub8cc\uc5d0 \uc911\uc694\ud55c \uc9c4\uc804\uc744 \uc758\ubbf8\ud569\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc2e0\uc57d\ub4e4\uc740 \ud658\uc790\ub4e4\uc5d0\uac8c \ub354 \ub098\uc740 \uce58\ub8cc \uc635\uc158\uc744 \uc81c\uacf5\ud558\uace0 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \ucd09\uc9c4\ud560 \uac83\uc73c\ub85c \uae30\ub300\ub429\ub2c8\ub2e4.<\/p>\n<p>*   PBC \uc720\ubcd1\ub960 \uc99d\uac00: \uc804 \uc138\uacc4\uc801\uc73c\ub85c \uc6d0\ubc1c\uc131 \ub2f4\uc999\uc131 \ub2f4\uad00\uc5fc(PBC)\uc758 \uc720\ubcd1\ub960\uc774 \uafb8\uc900\ud788 \uc99d\uac00\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud2b9\ud788 \uc5ec\uc131\uc5d0\uac8c\uc11c \ub354 \ud754\ud558\uac8c \ub098\ud0c0\ub098\ub294 \uc774 \ub9cc\uc131 \uc9c8\ud658\uc740 \uc870\uae30 \uc9c4\ub2e8\uacfc \ud6a8\uacfc\uc801\uc778 \uce58\ub8cc\uc758 \ud544\uc694\uc131\uc744 \uc99d\ub300\uc2dc\ud0a4\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc720\ubcd1\ub960 \uc99d\uac00\ub294 \uc790\uc5f0\uc2a4\ub7fd\uac8c \uce58\ub8cc\uc81c \uc218\uc694 \uc99d\uac00\ub85c \uc774\uc5b4\uc838 \uc2dc\uc7a5 \uc131\uc7a5\uc758 \uc8fc\uc694 \ub3d9\ub825\uc774 \ub429\ub2c8\ub2e4.<\/p>\n<p>*   \uc9c4\ub2e8 \uae30\uc220\uc758 \ubc1c\uc804: PBC \uc9c4\ub2e8 \uae30\uc220\uc758 \ubc1c\uc804\uc740 \uc9c8\ubcd1\uc758 \uc870\uae30 \ubc1c\uacac\uc728\uc744 \ub192\uc774\ub294 \ub370 \uae30\uc5ec\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud608\uc561 \uac80\uc0ac, \uac04 \uc0dd\uac80, \uc601\uc0c1 \uc9c4\ub2e8 \ub4f1 \ub2e4\uc591\ud55c \uc9c4\ub2e8 \ubc29\ubc95\uc758 \uac1c\uc120\uc740 \ud658\uc790\ub4e4\uc774 \uc801\uc2dc\uc5d0 \uce58\ub8cc\ub97c \uc2dc\uc791\ud560 \uc218 \uc788\ub3c4\ub85d \ub3d5\uace0, \uc774\ub294 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc758 \ud655\ub300\ub85c \uc774\uc5b4\uc9d1\ub2c8\ub2e4.<\/p>\n<p>*   \uc5f0\uad6c \uac1c\ubc1c \ud65c\ub3d9 \uc99d\uac00: \uc81c\uc57d \ud68c\uc0ac\ub4e4\uc740 PBC \uce58\ub8cc\ub97c \uc704\ud55c \uc0c8\ub85c\uc6b4 \uc57d\ubb3c \uac1c\ubc1c\uc5d0 \uc801\uadf9\uc801\uc73c\ub85c \ud22c\uc790\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uae30\uc874 \uce58\ub8cc\ubc95\uc5d0 \ubc18\uc751\ud558\uc9c0 \uc54a\uac70\ub098 \ubd80\uc791\uc6a9\uc744 \uacaa\ub294 \ud658\uc790\ub4e4\uc744 \uc704\ud55c \ud601\uc2e0\uc801\uc778 \uce58\ub8cc\uc81c \uac1c\ubc1c\uc740 \uc2dc\uc7a5\uc5d0 \uc0c8\ub85c\uc6b4 \uae30\ud68c\ub97c \ucc3d\ucd9c\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud2b9\ud788 \ud76c\uadc0 \uc9c8\ud658\uc5d0 \ub300\ud55c \uad00\uc2ec \uc99d\uac00\uc640 \uc815\ubd80\uc758 \uc778\uc13c\ud2f0\ube0c\ub294 \uc5f0\uad6c \uac1c\ubc1c \ud65c\ub3d9\uc744 \ub354\uc6b1 \ucd09\uc9c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>*   \uc778\uc2dd \uac1c\uc120 \ubc0f \uc758\ub8cc \uc811\uadfc\uc131 \ud5a5\uc0c1: PBC\uc5d0 \ub300\ud55c \ub300\uc911\uc758 \uc778\uc2dd\uacfc \uc758\ub8cc \uc804\ubb38\uac00\ub4e4\uc758 \uc774\ud574\uac00 \ub192\uc544\uc9c0\uba74\uc11c \uc9c4\ub2e8\uc728\uacfc \uce58\ub8cc\uc728\uc774 \ud5a5\uc0c1\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub610\ud55c, \uc758\ub8cc \uc2dc\uc2a4\ud15c\uc758 \ubc1c\uc804\uacfc \ubcf4\ud5d8 \uc801\uc6a9 \ud655\ub300\ub294 \ud658\uc790\ub4e4\uc774 \ud544\uc694\ud55c \uce58\ub8cc\ub97c \ubc1b\uc744 \uc218 \uc788\ub294 \uc811\uadfc\uc131\uc744 \ub192\uc5ec \uc2dc\uc7a5 \uc131\uc7a5\uc5d0 \uae0d\uc815\uc801\uc778 \uc601\ud5a5\uc744 \ubbf8 \ubbf8\uce58\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc6d0\ubc1c\uc131 \ub2f4\uc999\uc131 \ub2f4\uad00\uc5fc(Primary Biliary Cholangitis, PBC) \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc758 \uc804\ubc18\uc801\uc778 \ud604\ud669\uacfc \ubbf8\ub798 \uc804\ub9dd\uc744 \uc2ec\uce35\uc801\uc73c\ub85c \ubd84\uc11d\ud569\ub2c8\ub2e4. PBC\ub294 \ub2f4\uad00 \uc138\ud3ec\uc758 \ub290\ub9ac\uace0 \uc810\uc9c4\uc801\uc778 \ud30c\uad34\ub97c \ud2b9\uc9d5\uc73c\ub85c \ud558\ub294 \uc790\uac00\uba74\uc5ed\uc131 \uac04 \uc9c8\ud658\uc73c\ub85c, \ud604\uc7ac\uae4c\uc9c0 \uc2b9\uc778\ub41c \uce58\ub8cc \uc635\uc158\uc774 \uc81c\ud55c\uc801\uc778 \uc0c1\ud669\uc785\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uaddc\ubaa8\ub294 2031\ub144\uae4c\uc9c0 13\uc5b5 5\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \uc774\ub97c \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc8fc\uc694 \uc131\uc7a5 \ub3d9\ub825\uc73c\ub85c\ub294 FXR \uc791\uc6a9\uc81c\uc758 \ub300\uc0c1\uc131 \uac04\uacbd\ubcc0\uc99d\uc73c\ub85c\uc758 \uc801\uc751\uc99d \ud655\ub300, PPAR \uc791\uc6a9\uc81c\uc758 \uc2e0\uc18d \uc2b9\uc778, \ube44\uc6a9 \ud6a8\uc728\uc801\uc778 \uc6b0\ub974\uc18c\ub370\uc625\uc2dc\ucf5c\uc0b0(UDCA) \uc81c\ub124\ub9ad\uc758 \uc2dc\uc7a5 \uce68\ud22c, \uc0dd\ud654\ud559\uc801 \ubc18\uc751\uc790\uc5d0 \ub300\ud55c \uc2e4\uc81c \uc784\uc0c1 \ub370\uc774\ud130(RWE) \ucd95\uc801, \uc778\uacf5\uc9c0\ub2a5(AI) \uae30\ubc18\uc758 \uc870\uae30 \uc9c4\ub2e8 \uae30\uc220 \ubc1c\uc804, \uadf8\ub9ac\uace0 \ubcd1\uc6a9 \uc694\ubc95 \uc784\uc0c1 \uc2dc\ud5d8 \ud65c\ub3d9 \uc99d\uac00 \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4. \ud2b9\ud788 PPAR \uc791\uc6a9\uc81c\ub294 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 9.98%\uc758 \uac00\uc7a5 \ube60\ub978 \uc131\uc7a5\ub960\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, \uc774\ub294 \uc0dd\ud654\ud559\uc801 \uc815\uc0c1\ud654\uc640 \uac00\ub824\uc6c0\uc99d \uac10\uc18c\ub77c\ub294 \ubbf8\ucda9\uc871 \uc218\uc694\ub97c \ud574\uacb0\ud558\ub294 \ub370 \uae30\uc5ec\ud558\uae30 \ub54c\ubb38\uc785\ub2c8\ub2e4. \uc9c0\uc5ed\ubcc4\ub85c\ub294 \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc774 \ubcf4\ud5d8 \uc801\uc6a9 \ud655\ub300 \ubc0f \uc9c4\ub2e8 \uac1c\uc120\uc5d0 \ud798\uc785\uc5b4 \uc5f0\ud3c9\uade0 10.34%\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc778\uacf5\uc9c0\ub2a5(AI)\uc740 \uc9c4\ub2e8 \uc2dc\uac04\uc744 \ub2e8\ucd95\ud558\uace0 \uace0\uc704\ud5d8 \ud658\uc790\ub97c \uc2dd\ubcc4\ud558\uc5ec \uce58\ub8cc \ub300\uc0c1 \uc778\uad6c\ub97c \ud655\ub300\ud558\ub294 \ub370 \uc911\uc694\ud55c \uc5ed\ud560\uc744 \ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubc18\uba74, \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\uc73c\ub85c\ub294 \uace0\uc6a9\ub7c9 FXR \uc791\uc6a9\uc81c \uc0ac\uc6a9 \uc2dc \ubc1c\uc0dd\ud558\ub294 \uc2ec\ud55c \uac00\ub824\uc6c0\uc99d\uc73c\ub85c \uc778\ud55c \uce58\ub8cc \uc911\ub2e8\uc728, \ud53c\ube0c\ub808\uc774\ud2b8 \uacc4\uc5f4 \uc57d\ubb3c\uc758 \uadfc\ubcd1\uc99d \uad00\ub828 \ubd80\uc791\uc6a9, \uc774\uc2dd \uc5c6\ub294 \uc0dd\uc874\uc728(transplant-free survival)\uacfc \uac19\uc740 \uba85\ud655\ud55c \uc784\uc0c1 \uc885\ub9d0\uc810\uc758 \ubd80\uc7ac, \uadf8\ub9ac\uace0 \uc77c\ubc18 \uac1c\uc5c5\uc758\ub4e4 \uc0ac\uc774\uc758 \uc9c8\ud658 \uc778\uc9c0\ub3c4 \ubd80\uc871 \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubcf4\uace0\uc11c\ub294 \uc2dc\uc7a5\uc744 \uc57d\ubb3c \uacc4\uc5f4(\uc6b0\ub974\uc18c\ub370\uc625\uc2dc\ucf5c\uc0b0, \uc624\ubca0\ud2f0\ucf5c\uc0b0, PPAR \uc791\uc6a9\uc81c, \ud53c\ube0c\ub808\uc774\ud2b8 \ub4f1), \uc791\uc6a9 \uae30\uc804(FXR \uc791\uc6a9\uc81c, PPAR \u03b1\/\u03b4 \uc791\uc6a9\uc81c, \ub2f4\uc999\uc0b0 \uc870\uc808\uc81c, \ud56d\uc12c\uc720\ud654\uc81c, \uba74\uc5ed \uc870\uc808\uc81c), \uce58\ub8cc \ub77c\uc778(1\ucc28, 2\ucc28, \ubcd1\uc6a9), \uc720\ud1b5 \ucc44\ub110(\ubcd1\uc6d0 \uc57d\uad6d, \uc18c\ub9e4 \uc57d\uad6d, \uc628\ub77c\uc778 \uc57d\uad6d), \uadf8\ub9ac\uace0 \uc9c0\uc5ed(\ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8)\ubcc4\ub85c \uc138\ubd84\ud654\ud558\uc5ec \ubd84\uc11d\ud569\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd \ubd84\uc11d\uc5d0\uc11c\ub294 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4, \uc2dc\uc7a5 \uc810\uc720\uc728, \uadf8\ub9ac\uace0 Intercept Pharmaceuticals, Teva Pharmaceutical Industries, Viatris, Ipsen, Gilead Sciences, Novartis AG \ub4f1 \uc8fc\uc694 20\uac1c \uae30\uc5c5\uc758 \uc0c1\uc138 \ud504\ub85c\ud544\uc744 \ub2e4\ub8f9\ub2c8\ub2e4. \ubcf8 \ubcf4\uace0\uc11c\ub294 PBC \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc758 \ud604\uc7ac \ub3d9\ud5a5, \ubbf8\ub798 \uc131\uc7a5 \uc804\ub9dd, \uc8fc\uc694 \uae30\ud68c \ubc0f \ubbf8\ucda9\uc871 \uc218\uc694\uc5d0 \ub300\ud55c \ud3ec\uad04\uc801\uc778 \uc774\ud574\ub97c \uc81c\uacf5\ud568\uc73c\ub85c\uc368, \uad00\ub828 \uc774\ud574\uad00\uacc4\uc790\ub4e4\uc758 \uc804\ub7b5\uc801 \uc758\uc0ac\uacb0\uc815\uc744 \uc9c0\uc6d0\ud558\ub294 \ud575\uc2ec \uc815\ubcf4\ub97c \ub2f4\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-52776","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/52776"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=52776"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/52776\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=52776"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=52776"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=52776"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}